GlassScriptPhysician profile
Susan M Berberich
NPI 1891789749
$1,219.15
in general payments reported to CMS, 2019-2025
11 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $68.14 · 2021: $177 · 2022: $141 · 2023: $188 · 2024: $94.29 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $666.48 | 2019-2025 | Clareon, Clareon Panoptix Pro, Tryptyr |
| Aerie Pharmaceuticals, INC. | $299.86 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $61.94 | 2019-2021 | |
| Abbvie INC. | $41.73 | 2024-2025 | |
| Allergan, INC. | $34.81 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $25.12 | 2019-2020 | |
| Oyster Point Pharma, INC. | $24.50 | 2024 | Tyrvaya |
| Genentech USA, INC. | $24.36 | 2023 | Vabysmo |
| Rayner Intraocular Lenses Limited | $15.54 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $14.94 | 2020 | |
| Rxsight INC | $9.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Berberich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.